NCT01453855View on ClinicalTrials.gov

Travoprost 3-Month Safety and Efficacy Study

PHASE3CompletedINTERVENTIONAL

Enrollment

1,099

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions

Open-Angle GlaucomaOcular Hypertension

Interventions

DRUG

Travoprost ophthalmic solution, 0.003%

DRUG

Travoprost ophthalmic solution, 0.004%

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alcon Research

INDUSTRY